Effects of ozone and corticostroid on plantar fasciitis treatment

Not Applicable

• Conditions: Plantar fasciitis.; Diseases of the musculoskeletal system and connective tissue

• Registration Number: IRCT2017022124572N5
• Lead Sponsor: Vice Chancellor for research of Iran University Of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

History of plantar fasciitis, Patients suffering from heel pain with a VAS (Visual Analogue Scale) more than 4 for at least two months whose history, physical exam and sonography confirm plantar fasciitis. Exclusion criteria: A history of direct trauma; systemic inflammatory or soft tissue diseases; disk herniation with S1 radiculopathy; gout; diabetes mellitus; surgery or injection in fascia since 6 months ago, existence of cyst/mass in pain site; coincidence of paresthesia or numbness; coagulopathy; pregnancy; hypersensitivity to corticosteroids; infection of injection site, posterior heel pain and any treatment for the condition since 4 weeks ago; physiotherapy, splint, iontophoresis, iontophoresis, and shock-wave in the last 2 months.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Visual Analog Scale(VAS).

Secondary Outcome Measures

Name	Time	Method
Thickness of plantar fascia. Timepoint: before injection, 2 weeks and 8 weeks after injection. Method of measurement: sonography.;Thickness of plantar fascia. Timepoint: before injection, 2 weeks and 8 weeks after injection. Method of measurement: sonography.